Japan Anesthesia and Respiratory Devices Market Outlook to 2025 – Anesthesia Devices, Airway Management, Respiratory Devices and Diagnostic and Measurement Devices.

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995

“What is covered in the report about the “Japan Anesthesia and Respiratory Devices Market”?
GlobalData’s “Japan Anesthesia and Respiratory Devices Market Outlook to 2025” report is a comprehensive databook report, covering key market data on the Japan Anesthesia and Respiratory Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Airway Management, Anesthesia Devices, Diagnostic and Measurement Devices and Respiratory Devices.

The Japan Anesthesia and Respiratory Devices Market report provides key information and data on
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2018 company share and distribution share data for Anesthesia and Respiratory Devices market.
• Global corporate-level profiles of key companies operating within the Japan Anesthesia and Respiratory Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Japan Anesthesia and Respiratory Devices is segmented as follows:
• Airway Management
• Anesthesia Devices
• Diagnostic and Measurement Devices
• Respiratory Devices

Key Reasons to Purchase
The Japan Anesthesia and Respiratory Devices Market report helps you to develop
• Business strategies by identifying the key market segments poised for strong growth in the future.
• Market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the market.
• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “Japan Anesthesia and Respiratory Devices Market Outlook to 2025” report
• ResMed Inc
• Dragerwerk AG & Co KGaA
• Teleflex Inc
• Smiths Medical

The GlobalData Differentiation
Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.
The data and analysis within this report are driven by GlobalData Medical Equipment (GDME) databases. GlobalData Medical Equipment database gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 15,000+ primary interviews, conducted annually to ensure data and report quality
• 3,500+ industry-leading analysis and procedure reports covering growing sectors, market trends, investment opportunities and competitive landscape
• 66.956+ medical equipment company profiles
• 4,300+ company profiles of medical equipment manufacturers in China and India
• 825+ companies’ revenue splits and market shares
• 2,000+ quarterly and annual medical equipment company financials
• 1,100+ medical equipment company SWOTs
• 27,500+ pipeline product profiles
• 55,100+ marketed product profiles
• 46,100+ clinical trials
• 52,400+ trial investigators
• 7,900+ reports on companies with products in development
• 41,700+ deals in the medical equipment industry
For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx

Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

NA

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 10

2.1 What Is This Report About? 10

2.2 Anesthesia and Respiratory Devices market Segmentation 10

2.3 Definitions of Markets Covered in the Report 13

3 Anesthesia and Respiratory Devices Market, Japan 25

3.1 Anesthesia and Respiratory Devices Market, Japan, Revenue ($m), 2015-2025 25

3.2 Anesthesia and Respiratory Devices Market, Japan, Revenue Mix ($m), 2018 27

3.3 Anesthesia and Respiratory Devices Market, Japan, Category Contribution by Revenue ($m), 2018 28

3.4 Anesthesia and Respiratory Devices Market, Japan, Revenue ($m), 2015-2025 29

3.5 Anesthesia and Respiratory Devices Market, Japan, Volume (Units), 2015-2025 32

3.6 Anesthesia and Respiratory Devices Market, Japan, Volume (Units), 2015-2025 34

3.7 Anesthesia and Respiratory Devices Market, Japan, Company Share by Revenue ($m), 2018 37

4 Airway Management Market, Japan 40

4.1 Airway Management Market, Japan, Revenue Mix ($m), 2018 40

4.2 Airway Management Market, Japan, Segment Contribution (%), 2018 41

4.3 Airway Management Market, Japan, Revenue ($m), 2015-2025 42

4.3.1 Airway Management Masks Market, Japan, Revenue ($m), by Segment, 2015-2025 44

4.3.2 Airway Management Tubes Market, Japan, Revenue ($m), by Segment, 2015-2025 46

4.3.3 Intubation Accessories Market, Japan, Revenue ($m), by Segment, 2015-2025 49

4.4 Airway Management Market, Japan, Volume (Units), 2015-2025 52

4.4.1 Airway Management Masks Market, Japan, Volume (Units), by Segment, 2015-2025 54

4.4.2 Airway Management Tubes Market, Japan, Volume (Units), by Segment, 2015-2025 56

4.4.3 Intubation Accessories Market, Japan, Volume (Units), by Segment, 2015-2025 59

4.5 Airway Management Market, Japan, Average Price ($), 2015-2025 62

4.6 Airway Management Market, Japan, Distribution Share by Revenue ($m), 2018 64

4.7 Airway Management Market, Japan, Company Share by Revenue ($m), 2018 65

5 Anesthesia Devices Market, Japan 67

5.1 Anesthesia Devices Market, Japan, Revenue Mix ($m), 2018 67

5.2 Anesthesia Devices Market, Japan, Segment Contribution (%), 2018 68

5.3 Anesthesia Devices Market, Japan, Revenue ($m), 2015-2025 69

5.3.1 Anesthesia Circuits Market, Japan, Revenue ($m), by Segment, 2015-2025 72

5.3.2 Anesthesia Machines Market, Japan, Revenue ($m), by Segment, 2015-2025 74

5.3.3 Anesthesia Masks Market, Japan, Revenue ($m), by Segment, 2015-2025 76

5.3.4 Breathing Bags Market, Japan, Revenue ($m), by Segment, 2015-2025 78

5.3.5 Regional Anesthesia Disposables Market, Japan, Revenue ($m), by Segment, 2015-2025 80

5.4 Anesthesia Devices Market, Japan, Volume (Units), 2015-2025 83

5.4.1 Anesthesia Circuits Market, Japan, Volume (Units), by Segment, 2015-2025 86

5.4.2 Anesthesia Machines Market, Japan, Volume (Units), by Segment, 2015-2025 88

5.4.3 Anesthesia Masks Market, Japan, Volume (Units), by Segment, 2015-2025 90

5.4.4 Breathing Bags Market, Japan, Volume (Units), by Segment, 2015-2025 92

5.4.5 Regional Anesthesia Disposables Market, Japan, Volume (Units), by Segment, 2015-2025 94

5.5 Anesthesia Devices Market, Japan, Average Price ($), 2015-2025 97

5.6 Anesthesia Devices Market, Japan, Distribution Share by Revenue ($m), 2018 99

5.7 Anesthesia Devices Market, Japan, Company Share by Revenue ($m), 2018 100

6 Diagnostic and Measurement Devices Market, Japan 102

6.1 Diagnostic and Measurement Devices Market, Japan, Revenue Mix ($m), 2018 102

6.2 Diagnostic and Measurement Devices Market, Japan, Segment Contribution (%), 2018 103

6.3 Diagnostic and Measurement Devices Market, Japan, Revenue ($m), 2015-2025 104

6.3.1 Capnographs Market, Japan, Revenue ($m), by Segment, 2015-2025 107

6.3.2 Pulse Oximeter Systems Market, Japan, Revenue ($m), by Segment, 2015-2025 109

6.3.3 Sleep Apnea Diagnostic Systems Market, Japan, Revenue ($m), by Segment, 2015-2025 112

6.3.4 Spirometers Market, Japan, Revenue ($m), by Segment, 2015-2025 114

6.4 Diagnostic and Measurement Devices Market, Japan, Volume (Units), 2015-2025 116

6.4.1 Capnographs Market, Japan, Volume (Units), by Segment, 2015-2025 119

6.4.2 Pulse Oximeter Systems Market, Japan, Volume (Units), by Segment, 2015-2025 121

6.4.3 Sleep Apnea Diagnostic Systems Market, Japan, Volume (Units), by Segment, 2015-2025 124

6.4.4 Spirometers Market, Japan, Volume (Units), by Segment, 2015-2025 126

6.5 Diagnostic and Measurement Devices Market, Japan, Average Price ($), 2015-2025 128

6.6 Diagnostic and Measurement Devices Market, Japan, Distribution Share by Revenue ($m), 2018 130

6.7 Diagnostic and Measurement Devices Market, Japan, Company Share by Revenue ($m), 2018 131

7 Respiratory Devices Market, Japan 133

7.1 Respiratory Devices Market, Japan, Revenue Mix ($m), 2018 133

7.2 Respiratory Devices Market, Japan, Segment Contribution (%), 2018 134

7.3 Respiratory Devices Market, Japan, Revenue ($m), 2015-2025 135

7.3.1 Nebulizers Market, Japan, Revenue ($m), by Segment, 2015-2025 138

7.3.2 Non-Invasive Ventilation Masks & Circuits Market, Japan, Revenue ($m), by Segment, 2015-2025 140

7.3.3 Oxygen Concentrators Market, Japan, Revenue ($m), by Segment, 2015-2025 142

7.3.4 Oxygen Conservers Market, Japan, Revenue ($m), by Segment, 2015-2025 144

7.3.5 Positive Airway Pressure Devices Market, Japan, Revenue ($m), by Segment, 2015-2025 146

7.3.6 Respiratory Device Accessories Market, Japan, Revenue ($m), by Segment, 2015-2025 148

7.3.7 Ventilators Market, Japan, Revenue ($m), by Segment, 2015-2025 151

7.4 Respiratory Devices Market, Japan, Volume (Units), 2015-2025 153

7.4.1 Nebulizers Market, Japan, Volume (Units), by Segment, 2015-2025 156

7.4.2 Non-Invasive Ventilation Masks & Circuits Market, Japan, Volume (Units), by Segment, 2015-2025 158

7.4.3 Oxygen Concentrators Market, Japan, Volume (Units), by Segment, 2015-2025 160

7.4.4 Oxygen Conservers Market, Japan, Volume (Units), by Segment, 2015-2025 162

7.4.5 Positive Airway Pressure Devices Market, Japan, Volume (Units), by Segment, 2015-2025 164

7.4.6 Respiratory Device Accessories Market, Japan, Volume (Units), by Segment, 2015-2025 166

7.4.7 Ventilators Market, Japan, Volume (Units), by Segment, 2015-2025 169

7.5 Respiratory Devices Market, Japan, Average Price ($), 2015-2025 171

7.6 Respiratory Devices Market, Japan, Distribution Share by Revenue ($m), 2018 175

7.7 Respiratory Devices Market, Japan, Company Share by Revenue ($m), 2018 176

8 Overview of Key Companies in Japan, Anesthesia and Respiratory Devices Market 178

8.1 Teleflex Inc 178

8.1.1 Company Overview 178

8.2 Medtronic Plc 178

8.2.1 Company Overview 178

8.3 Smiths Medical 178

8.3.1 Company Overview 178

8.4 Dragerwerk AG & Co KGaA 179

8.4.1 Company Overview 179

8.5 ResMed Inc 179

8.5.1 Company Overview 179

8.6 GE Healthcare LLC 179

8.6.1 Company Overview 179

8.7 Koninklijke Philips NV 179

8.7.1 Company Overview 179

8.8 Ambu A/S 180

8.8.1 Company Overview 180

8.9 Nihon Kohden Corp 180

8.9.1 Company Overview 180

8.10 Intersurgical Ltd. 180

8.10.1 Company Overview 180

8.11 Becton Dickinson and Co 180

8.11.1 Company Overview 180

8.12 Medline Industries Inc 181

8.12.1 Company Overview 181

8.13 Masimo Corp 181

8.13.1 Company Overview 181

8.14 Fisher & Paykel Healthcare Corporation Ltd 181

8.14.1 Company Overview 181

8.15 Nonin Medical Inc 181

8.15.1 Company Overview 181

8.16 Natus Medical Incorporated 182

8.16.1 Company Overview 182

8.17 GIMA, SpA 182

8.17.1 Company Overview 182

8.18 B. Braun Melsungen AG 182

8.18.1 Company Overview 182

8.19 Philips Respironics Inc 182

8.19.1 Company Overview 182

8.20 Air Liquide SA 183

8.20.1 Company Overview 183

8.21 Vyaire Medical Inc 183

8.21.1 Company Overview 183

8.22 Maquet AG 183

8.22.1 Company Overview 183

8.23 DeVilbiss Healthcare LLC 183

8.23.1 Company Overview 183

8.24 Senko Medical Instrument Manufacturing Co.,Ltd. 184

8.24.1 Company Overview 184

8.25 Hamilton Medical AG 184

8.25.1 Company Overview 184

9 Anesthesia and Respiratory Devices Market Pipeline Products 185

10 Financial Deals Landscape 187

10.1 Partnerships 187

10.1.1 R2 Dermatology Enters into Distribution Agreement with Huadong Medicine Company 187

10.1.2 Shenzhen Mindray Bio-Medical Electronics Enters into Licensing Agreement with Masimo 188

11 Recent Developments 189

11.1 Corporate Communications 189

11.1.1 Jul 31, 2019: New imaging method is more effective at detecting prostate cancer recurrence than standard scan 189

11.1.2 Jun 14, 2019: Announcement of new appointments to Board of Directors at PHC Holdings and PHC 190

11.1.3 Jun 03, 2019: Parexel appoints Dr. Makoto Sugita to lead its Japan organization 190

11.1.4 May 21, 2019: Nihon Kohden announces nomination of Candidates for Directors 191

11.1.5 Apr 01, 2019: Inauguration address of new president and CEO of PHC Holdings 191

11.1.6 Feb 21, 2019: Nihon Kohden appoints new CEO of North American operations 192

11.1.7 Feb 04, 2019: Teijin board elects Ichiro Watanabeas new president of Teijin Pharm 192

11.1.8 Feb 04, 2019: Teijin Limited has made the following personnel changes effective as of June 20, 2019 193

11.2 Financial Announcements 193

11.2.1 Aug 01, 2019: Nihon Kohden announces FY2019 first quarter consolidated financial results 193

11.2.2 Jul 25, 2019: ResMed announces results for the fourth quarter of fiscal year 2019 194

11.2.3 Jun 26, 2019: Clinical Trial of new Cardiovascular Patch Launched 195

11.2.4 May 15, 2019: Apollo Endosurgery to participate in Digestive Disease Week 2019 196

11.2.5 May 02, 2019: ResMed announces results for the third quarter of fiscal year 2019 197

11.2.6 Feb 04, 2019: Teijin: Consolidated financial statements summary for the the nine months ended December 31, 2018 198

11.2.7 Jan 24, 2019: ResMed announces results for the second quarter of fiscal year 2019 200

11.3 Other Significant Developments 201

11.3.1 Jan 25, 2019: Improving drug development and patient access with the right people, processes, and culture 201

11.4 Product News 205

11.4.1 Oct 15, 2019: Onxeo to present final results of DRIIV-1 phase 1 study of AsiDNA in advanced solid tumors at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 205

11.4.2 Jun 05, 2019: A&D Medical launches new line of Professional Blood Pressure Monitors 206

11.4.3 Apr 18, 2019: EarlySense to serve as technology engine for improved sleep projects in Japan 207

11.4.4 Jan 09, 2019: Aptar Pharma: Pulmonary and nasal drug delivery experts to attend RDD Europe 2019 208

11.5 Research And Development 208

11.5.1 Oct 15, 2019: Onxeo to present final results of DRIIV-1 phase 1 study of AsiDNA in advanced solid tumors at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 208

11.6 Strategy And Business Planning 209

11.6.1 Jul 26, 2019: Neural Analytics announces strategic partnership with NGK SPARK PLUG 209

11.6.2 May 13, 2019: Nihon Kohden establishes a hematology analyzer reagent factory in Dubai 210

12 Appendix 211

12.1 Research Methodology 212

12.1.1 Coverage 212

12.1.2 Secondary Research 212

12.1.3 Primary Research 213

12.1.4 Market Modeling and Forecasting 214

12.1.5 Company Share Analysis 215

12.1.6 Distribution Share Analysis 216

12.1.7 Benchmarking 216

12.2 GlobalData Consulting 217

12.3 Contact Us 217

12.4 Disclaimer 217

Frequently asked questions

Japan Anesthesia and Respiratory Devices Market Outlook to 2025 – Anesthesia Devices, Airway Management, Respiratory Devices and Diagnostic and Measurement Devices. thematic reports
Currency USD
$5,995

Can be used by individual purchaser only

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Japan Anesthesia and Respiratory Devices Market Outlook to 2025 – Anesthesia Devices, Airway Management, Respiratory Devices and Diagnostic and Measurement Devices. in real time.

  • Access a live Japan Anesthesia and Respiratory Devices Market Outlook to 2025 – Anesthesia Devices, Airway Management, Respiratory Devices and Diagnostic and Measurement Devices. dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.